Mersana Therapeutics, Inc. (MRSN)

Heartland Financial USA Revenue

Mersana Therapeutics had revenue of $2.75M in the quarter ending March 31, 2025, a decrease of -70.21%. This brings the company's revenue in the last twelve months to $34.01M, down -11.21% year-over-year. In the year 2024, Mersana Therapeutics had annual revenue of $40.50M with 9.88% growth.

• Revenue (ttm): $34.01M
• Revenue Growth: -11.21%
• P/S Ratio: 0.96
• Revenue / Employee: $333,392
• Employees: 102
• Market Cap: 32.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	40.50M	3.64M	9.88%
Dec 31, 2023	36.86M	10.27M	38.65%
Dec 31, 2022	26.58M	26.54M	61,716.28%
Dec 31, 2021	43.00K	-785.00K	-94.81%
Dec 31, 2020	828.00K	-41.30M	-98.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.